# Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1

> **NCT00249574** · NA · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 10 (estimated)

## Conditions studied

- Hepatitis C
- Heroin Dependence

## Interventions

- **DRUG:** Buprenorphine/naloxone
- **DRUG:** pegInterferon

## Key facts

- **NCT ID:** NCT00249574
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-03
- **Final completion:** 2006-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249574, "Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00249574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*